» Articles » PMID: 37114072

Rs671 Polymorphism Likely a Risk Factor for Hemorrhagic Stroke: A Hospital-Based Study

Overview
Journal Int J Gen Med
Publisher Dove Medical Press
Specialty General Medicine
Date 2023 Apr 28
PMID 37114072
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypertension is the main risk factor for hemorrhagic stroke. Aldehyde dehydrogenase 2 (ALDH2) may inhibit the occurrence of hypertension by anti-oxidative stress and vascular dilation. The purpose was to investigate the relationship of polymorphisms with hemorrhagic stroke in Hakka Chinese.

Methods: A total of 329 patients with hemorrhagic stroke and 515 controls were enrolled, and medical records (smoking and drinking history, hypertension, and diabetes) were collected. The genotypes of rs671 of the two groups were detected and analyzed.

Results: The proportion of the rs671 G/G, G/A, and A/A genotype in patients with hemorrhagic stroke was 55.9%, 37.4%, and 6.7%, respectively, while those were 65.0%, 30.7%, and 4.3% in controls, respectively. There was statistically significant difference in rs671 genotypes distribution (=0.021) and alleles distribution (=0.005) between patients and controls. Among hemorrhagic stroke patients, no statistically significant differences were observed between patients with different genotypes. Logistic regression analysis showed that there was significantly high risk of hemorrhagic stroke in men (male vs female: adjusted OR 1.711, 95% CI 1.154-2.538, =0.008), the presence of hypertension (with vs without hypertension: adjusted OR 16.095, 95% CI 10.958-23.641, <0.001), and the presence of rs671 G/A genotype (G/A vs G/G: adjusted OR 1.679, 95% CI 1.151-2.450, =0.007) or A/A genotype (A/A vs G/G: adjusted OR 2.516, 95% CI 1.132-5.591, =0.024).

Conclusion: rs671 polymorphism likely a risk factor for hemorrhagic stroke.

Citing Articles

Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis.

Fan M, Li N, Huang L, Chen C, Dong X, Gao W Cardiovasc Ther. 2025; 2025:5711316.

PMID: 40026415 PMC: 11870767. DOI: 10.1155/cdr/5711316.


The Applicability and Limitations of the Spectrofluorometric Method for Determination of ALDH1 Activity in Serum and Plasma.

Michorowska S, Wisniewska A, Wolinowska R, Wroczynski P, Giebultowicz J Diagnostics (Basel). 2024; 14(23).

PMID: 39682629 PMC: 11640014. DOI: 10.3390/diagnostics14232721.


The ALDH2 gene rs671 polymorphism is associated with cardiometabolic risk factors in East Asian population: an updated meta-analysis.

Liu R, Peng M, Zhang J, Qiu K, Zeng T, Chen L Front Endocrinol (Lausanne). 2024; 15:1333595.

PMID: 38567307 PMC: 10986734. DOI: 10.3389/fendo.2024.1333595.

References
1.
Wu H, Huang Q, Yu Z, Zhong Z . Association of ALDH2 rs671 and MTHFR rs1801133 polymorphisms with hypertension among Hakka people in Southern China. BMC Cardiovasc Disord. 2022; 22(1):128. PMC: 8962465. DOI: 10.1186/s12872-022-02577-x. View

2.
Hathidara M, Saini V, Malik A . Stroke in the Young: a Global Update. Curr Neurol Neurosci Rep. 2019; 19(11):91. DOI: 10.1007/s11910-019-1004-1. View

3.
Ekkert A, Sliachtenko A, Grigaite J, Burnyte B, Utkus A, Jatuzis D . Ischemic Stroke Genetics: What Is New and How to Apply It in Clinical Practice?. Genes (Basel). 2022; 13(1). PMC: 8775228. DOI: 10.3390/genes13010048. View

4.
Ganaie H, Biswas A, Bhattacharya A, Pal S, Ray J, Das S . Association of Gene Polymorphism with Stroke Patients from Rural Eastern India. Ann Indian Acad Neurol. 2020; 23(4):504-509. PMC: 7657292. DOI: 10.4103/aian.AIAN_45_19. View

5.
Geltser B, Kurpatov I, Kotelnikov V, Zayats Y . Chronic obstructive pulmonary disease and cerebrovascular diseases: functional and clinical aspect of comorbidity. Ter Arkh. 2019; 90(3):81-88. DOI: 10.26442/terarkh201890381-88. View